ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

US News

For ExxonMobil Problems Are Opportunities

17 Jun 2014 @ 02:51
The share price of ExxonMobil (NYSE:XOM) hit a 52-week high in early trading this morning at 103.25. It is currently at 102.97 at 11:10 EDT, up 0.30% from Friday’s close. The share price low point for the 12-month period was 84.79, reached in October 2013. ExxonMobil may be a giant among giants, but its sheer […]
 

Will Iraq Wreck World Economic Recovery?

13 Jun 2014 @ 08:13
Is it possible that what happens within the country of Iraq, a veritable poster child for middle eastern turmoil, could have so great an impact as to cause the fragile economic recovery to collapse? The worry on the street is that the answer is “Yes.” The world is a crazy place to live, but it’s […]
 

US Treasury to sell preferred stock

13 Jun 2014 @ 07:57
Fancy selling out? As part of its ongoing efforts to wind down the Troubled Asset Relief Program (TARP) and recover its remaining Capital Purchase Program (CPP) investments, the U.S. Department of the Treasury today announced its intention to sell several preferred stock CPP investments. The Treasury intends to conduct auctions for all of its preferred […]
 

Cesca announces proposed public offering

13 Jun 2014 @ 07:54
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today that it intends to offer Units consisting of its shares of common stock and warrants to purchase shares of common stock in an underwritten public offering. The shares of common stock and warrants comprising the units are immediately separable. All of the Units […]
 

TRX Will Help U.S. Veterans Heal Wounds

13 Jun 2014 @ 07:04
York-based Tissue Regenix (LSE:TRX) announced this morning that it has launched it DermaPure™ product in the U.S. and will be shipping product to customers next week. The TRX share price gained 27.27% to 26.50 on the day as investors demonstrated their enthusiasm in support of the projected addition $1.4 billion USD per year. The company […]
 

Lufthansa & Airbus on Wing & a Prayer

12 Jun 2014 @ 06:42
Wednesday was a bad day for two major airline giants, one a manufacturer and the other a commercial airline. The share prices of Airbus (EU:AIR) and Lufthansa (LS:LHA) both suffered following very unflattering reports. Airbus Loses Order. Share Price Drops More Than 3%. Emirates airline cancelled an order for 50 Airbus A350-900s and 20 A350-1000s, […]
 

Hexis Cyber Solutions lands US Government deal

12 Jun 2014 @ 06:37
Hexis Cyber Solutions, Inc. (Hexis), a wholly-owned subsidiary of The KEYW Holding Corporation (Nasdaq:KEYW), and a provider of advanced cybersecurity solutions for commercial companies and government agencies, today announced that a leading U.S. government agency has taken an initial delivery of its next-generation threat investigation and automated malware removal solution, HawkEye G, to...
 

StoneMor Partners give traders hope of profit in the afterlife

11 Jun 2014 @ 08:43
Acquisition of Funeral Homes & Cemeteries from Service Corporation International StoneMor Partners L.P. announced today that it has closed the previously announced purchase of 9 funeral homes, 12 cemeteries and 2 crematories from Service Corporation International (NYSE:SCI). StoneMor paid approximately $53.8 million in cash for the properties which are located in Central Florida, North...
 

Is GKP the Poster Child for Bad Luck?

11 Jun 2014 @ 02:07
Sometimes I think that if it were not for bad luck, Gulf Keystone Petroleum (LSE:GKP) would have no luck at all. It seems like every time the company catches a break, something goes wrong. The GKP share price was down 0.58% today to 90.47, much closer to the low end of its 52-week range of […]
 

Merck Acquisition Benefits Patients and Investors

10 Jun 2014 @ 01:45
Pharmaceutical giant Merck (NYSE:MRK) announced today that it has agreed to acquire Idenix Pharmaceuticals (NASDAQ:IDIX) for $3.85 billion. Even compared to the now defunct attempt of Pfizer (NYSE:PFE) to acquire AstraZeneca (LSE:AZN), this could be one of the biggest acquisitions of all time in this sector, not necessarily in volume, but in impact. It appears […]
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com